Nonalcoholic fatty liver disease: from pathogenesis to patient care.
about
Atf4 regulates obesity, glucose homeostasis, and energy expenditureEndothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in miceLiver Function Test Abnormalities in Depressed Patients Treated with Antidepressants: A Real-World Systematic Observational Study in Psychiatric SettingsGPRC6A null mice exhibit osteopenia, feminization and metabolic syndromeCentral nervous system melanocortin-3 receptors are required for synchronizing metabolism during entrainment to restricted feeding during the light cycle.Nitric oxide and redox regulation in the liver: Part I. General considerations and redox biology in hepatitisSinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD.Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance.Blockade of class IB phosphoinositide-3 kinase ameliorates obesity-induced inflammation and insulin resistance.Genetic dissection of the functions of the melanocortin-3 receptor, a seven-transmembrane G-protein-coupled receptor, suggests roles for central and peripheral receptors in energy homeostasis.Vascular and hepatic impact of short-term intermittent hypoxia in a mouse model of metabolic syndromeHepatic Src homology phosphatase 2 regulates energy balance in mice.Chlorogenic acid improves high fat diet-induced hepatic steatosis and insulin resistance in mice."Non alcoholic fatty liver disease and eNOS dysfunction in humans"Dietary licorice root supplementation reduces diet-induced weight gain, lipid deposition, and hepatic steatosis in ovariectomized mice without stimulating reproductive tissues and mammary glandSirt1 protects against high-fat diet-induced metabolic damage.Characteristics of common solid liver lesions and recommendations for diagnostic workup.Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism.Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice.Adropin deficiency is associated with increased adiposity and insulin resistance.CXCR4 dysfunction in non-alcoholic steatohepatitis in mice and patients.Characterisation of Agomelatine-Induced Increase in Liver Enzymes: Frequency and Risk Factors Determined from a Pooled Analysis of 7605 Treated Patients.Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes.Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice.Interleukin-32β ameliorates metabolic disorder and liver damage in mice fed high-fat diet.Decreased adiposity and enhanced glucose tolerance in shikonin treated mice.Selective impairment in dendritic cell function and altered antigen-specific CD8+ T-cell responses in diet-induced obese mice infected with influenza virus.Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice.Body fat distribution and risk factors for fibrosis in patients with alcoholic liver disease.Approach to Solid Liver Masses in the Cirrhotic Patient.In vivo (1)H-MRS hepatic lipid profiling in nonalcoholic fatty liver disease: an animal study at 9.4 T.Cardiovascular risk factors in primary Sjögren's syndrome: a case-control study in 624 patients
P2860
Q24648259-54198121-25BC-48A0-9A03-BA06DAC72867Q24652041-1E716E95-7A2B-48A5-BAF2-567C6811B856Q28552027-C17ADB18-4EB8-4CC2-A3F1-31FDE4DC6AC4Q30440683-DC1BF24D-835A-43B3-9483-6B1DC01658C8Q33694606-13D957DA-4A7B-4C31-96BD-3EEF60D22F22Q33912904-E26ED962-BE58-4077-8061-460E1A0C4DABQ34234946-6E0E485D-F14C-4E29-BE4B-72D31F85DCAAQ34325594-3CD6C62A-C2B5-4A36-85CF-7EE6CB464A4AQ34804886-1AA732F4-3700-42A4-A494-7586E5A0A384Q35562552-3A7B0A5D-6DD9-4D84-B784-EAF642EFD130Q35636669-25D67E95-A7C1-4FD0-80AB-2520D81E6561Q36049875-1AAE5B73-C39B-4329-BB18-54E3B81C1D3CQ36129442-8444847B-6038-4D3A-98A8-50944B1C20E7Q36298719-85FFC7A1-2343-4809-B05B-3CDAD6FE06C4Q36535547-117A6F79-0A77-447F-BB13-B43C3A6A7502Q36775324-AB796D8C-22BF-440A-B471-93853CE9F144Q37262038-7E24A38D-E57D-4957-B596-7AC6F5A0CE0DQ37352148-60817B7D-D74B-44FE-8340-678351209B72Q37371469-95133A23-E819-42C9-8FE8-683BAA9DDC4EQ37527258-DFE78384-1837-45EF-95A2-ADE99C1BD474Q38305411-89EACE28-4BCA-4581-A46C-DAE72D5A9BF9Q38876395-9715298C-9BB8-4897-A000-5F234C10D939Q39170225-4B38642E-F3AD-47E8-A1BB-AC7AB24DA776Q41478592-92269846-67ED-4FFF-B67B-48B611EC0EB9Q41489654-1403F6E1-47FF-4281-8F36-CC63DAEB9604Q41851884-476D97D0-8D23-44D8-853D-3F7375164BE8Q45391773-D02D0A22-CF13-4FDE-BE1A-5691B6E3F889Q46010720-44536581-2993-4EAF-B36A-5E473052743CQ46419710-19B5D0B5-2ABB-4978-9F6B-A4DF9C24119BQ47095051-81E52ED1-5895-4771-9EDD-335C185A9345Q53358958-9C48FE75-25B9-4850-B48D-7C0A99F46F7DQ56907410-4DC1967E-70A3-45C8-86BC-1056B71ADA81
P2860
Nonalcoholic fatty liver disease: from pathogenesis to patient care.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Nonalcoholic fatty liver disease: from pathogenesis to patient care.
@en
type
label
Nonalcoholic fatty liver disease: from pathogenesis to patient care.
@en
prefLabel
Nonalcoholic fatty liver disease: from pathogenesis to patient care.
@en
P2093
P356
P1476
Nonalcoholic fatty liver disease: from pathogenesis to patient care
@en
P2093
Amélie Bigorgne
Gabriel Perlemuter
Sylvie Naveau
P304
P356
10.1038/NCPENDMET0505
P577
2007-06-01T00:00:00Z